Abbott’s 2Q profits beat Wall Street expectations with growing sales in emerging markets

Abbott Laboratories said second-quarter adjusted profit rose 16 percent, better than Wall Street expected, as growth in its nutrition and diagnostics segments more than offset declines in medical devi…
Read the full story: MedCity News